Matches in Wikidata for { <http://www.wikidata.org/entity/Q94144092> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q94144092 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94144092 description "wetenschappelijk artikel" @default.
- Q94144092 description "наукова стаття, опублікована в жовтні 2019" @default.
- Q94144092 name "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 name "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 type Item @default.
- Q94144092 label "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 label "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 prefLabel "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 prefLabel "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2" @default.
- Q94144092 P1433 Q94144092-76CAE83C-D234-4EA7-AEA0-6E109FCD50AF @default.
- Q94144092 P1476 Q94144092-67376B5C-5160-466D-8675-144E21AAC67D @default.
- Q94144092 P2093 Q94144092-1BD4CD93-216B-4178-ADB7-EF091CCB8835 @default.
- Q94144092 P2093 Q94144092-2B15991D-37F4-408B-B161-6C31ABFC9CCA @default.
- Q94144092 P2093 Q94144092-598A74CB-4E0C-4AA6-BF3C-762113BDE213 @default.
- Q94144092 P2093 Q94144092-8057AF23-1346-4141-B958-46737520FEA1 @default.
- Q94144092 P2093 Q94144092-D884EDA1-6C10-4349-AEF8-67DB37994D17 @default.
- Q94144092 P2093 Q94144092-F2C1FC5C-E9AE-4593-BE76-CB032EDC2B85 @default.
- Q94144092 P275 Q94144092-19404bd6-0bdf-4113-9c9d-504996a1fa62 @default.
- Q94144092 P304 Q94144092-3EF96504-B273-4A86-A479-16889F564B50 @default.
- Q94144092 P31 Q94144092-87BE76A7-0A5B-44EF-A89E-927D3BFA6411 @default.
- Q94144092 P356 Q94144092-4937BC6E-5F16-4BA9-86C7-A0BE7ECD30BA @default.
- Q94144092 P407 Q94144092-4039AA0E-2B5A-4955-AF91-1C10835D7183 @default.
- Q94144092 P433 Q94144092-E7B83B98-C37F-4797-8F7A-CA01AB638624 @default.
- Q94144092 P478 Q94144092-F6A4C2CF-89E7-46D6-BA31-737E65DEEC03 @default.
- Q94144092 P50 Q94144092-06ACC40E-7E6B-4BE1-98AD-40AC6ACE344B @default.
- Q94144092 P577 Q94144092-F98A8F9F-8DE6-4898-A6F7-2FF7F4C854F7 @default.
- Q94144092 P6216 Q94144092-0e606290-3c25-4578-a769-a7f24496d523 @default.
- Q94144092 P921 Q94144092-3599A07B-93C9-4311-AFDA-D59EFBDE59B7 @default.
- Q94144092 P921 Q94144092-6F002E93-77DA-4586-B0C5-4212B1A3A8C9 @default.
- Q94144092 P932 Q94144092-0D2E2FE9-CAAB-4A5E-8EE5-BC95548FA7A3 @default.
- Q94144092 P356 OFZ360.732 @default.
- Q94144092 P1433 Q27725953 @default.
- Q94144092 P1476 "664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes" @default.
- Q94144092 P2093 "Anita F Das" @default.
- Q94144092 P2093 "Christian Sandrock" @default.
- Q94144092 P2093 "Elizabeth Alexander" @default.
- Q94144092 P2093 "Gregory J Moran" @default.
- Q94144092 P2093 "Jennifer Schranz" @default.
- Q94144092 P2093 "Steven P Gelone" @default.
- Q94144092 P275 Q24082749 @default.
- Q94144092 P304 "S304-S305" @default.
- Q94144092 P31 Q13442814 @default.
- Q94144092 P356 "10.1093/OFID/OFZ360.732" @default.
- Q94144092 P407 Q1860 @default.
- Q94144092 P433 "Suppl 2" @default.
- Q94144092 P478 "6" @default.
- Q94144092 P50 Q124419900 @default.
- Q94144092 P577 "2019-10-23T00:00:00Z" @default.
- Q94144092 P6216 Q50423863 @default.
- Q94144092 P921 Q1241025 @default.
- Q94144092 P921 Q3776920 @default.
- Q94144092 P932 "6811114" @default.